| 09:30 - 10:45 | 184 | CCC Respiratory critical care | Challenging clinical cases |
| 09:30 - 11:00 | 185 | Asthma treatment: clinical and translational science | Oral Presentation |
| 09:30 - 11:00 | 186 | Adult cystic fibrosis | Oral Presentation |
| 09:30 - 11:00 | 187 | Nursing perspective during the COVID-19 pandemic | Oral Presentation |
| 09:30 - 11:00 | 188 | Novel insights into the diagnosis, mechanism and treatment of malignant pleural disease | Oral Presentation |
| 09:30 - 11:00 | 189 | New technologies for the management of children with respiratory diseases | Symposium |
| 09:30 - 11:00 | 190 | Interstitial lung diseases | State of the art session |
| 09:30 - 11:00 | 191 | Highlights on gender and respiratory health | Symposium |
| 09:30 - 10:45 | 193 | Part I: restarting COPD care in the post-COVID era | Primary care session |
| 09:30 - 11:00 | 194 | Imaging | Oral Presentation |
| 10:00 - 12:00 | 195 | Respiratory sleep | Skills lab |
| 10:55 - 12:10 | 198 | Part II: restarting asthma care in the post-COVID era | Primary care session |
| 11:15 - 12:45 | 203 | Updates on inhalers for COPD and asthma | Joint session |
| 11:15 - 12:45 | 204 | Patient-reported outcome measures (PROMs): easy tools in the management of chronic respiratory diseases | Oral Presentation |
| 11:15 - 12:45 | 205 | Advances in treatment and management of tuberculosis and nontuberculous mycobacterial disease | Oral Presentation |
| 11:15 - 12:45 | 206 | Paediatric lung disease: novel mechanisms, methods and translational studies | Oral Presentation |
| 11:15 - 12:45 | 207 | New trends in non-invasive respiratory support | Oral Presentation |
| 11:15 - 12:45 | 208 | Wheezing illnesses along the life span | Symposium |
| 11:15 - 12:45 | 209 | LoF Interstitial lung diseases? | Lungs on fire |
| 11:15 - 12:45 | 210 | Sarcopenia in chronic respiratory disease: new definitions, assessment and treatment options | Symposium |
| 11:15 - 12:45 | 211 | Digital transformation in practice: enabling next-generation medicine | Symposium |
| 11:15 - 12:45 | 212 | Respiratory infections | Oral Presentation |
| 12:20 - 13:00 | 214 | The current classification of pulmonary hypertension meets clinical practice | Pro-Con debate |
| 12:50 - 15:00 | 219 | Thoracic ultrasound | Skills lab |
| 13:15 - 14:15 | 227 | Epidemiology and burden of tuberculosis and other lung diseases | E-poster |
| 13:15 - 14:15 | 228 | Pneumonia | E-poster |
| 13:15 - 14:15 | 229 | Acute non-invasive respiratory therapies in COVID-19 and beyond | E-poster |
| 13:15 - 14:15 | 230 | Environment and air pollution | E-poster |
| 13:15 - 14:15 | 231 | Innovations in nurse-led interventions in respiratory diseases | E-poster |
| 13:15 - 14:15 | 232 | Physical activity, exercise training and (tele)rehabilitation in respiratory patients | E-poster |
| 13:15 - 14:15 | 233 | Treatments for airway diseases | E-poster |
| 13:15 - 14:15 | 234 | Lung function testing in the management of obstructive diseases | E-poster |
| 13:15 - 14:15 | 235 | Pulmonary neoplasia and related pathologies | E-poster |
| 13:15 - 14:15 | 236 | Fungi, viruses, parasites and the immunocompromised | E-poster |
| 13:15 - 14:15 | 237 | Occupational rhinitis and asthma | E-poster |
| 13:15 - 14:15 | 238 | Therapy of pulmonary hypertension | E-poster |
| 13:15 - 14:15 | 239 | Management of chronic cough and obstructive diseases | E-poster |
| 13:15 - 14:15 | 240 | Acute paediatric respiratory infections | E-poster |
| 13:15 - 14:15 | 241 | Rare thoracic surgical disease and the chest wall | E-poster |
| 13:15 - 14:15 | 242 | Pulmonary rehabilitation in clinical conditions | E-poster |
| 13:15 - 14:15 | 243 | Bronchiectasis and pleural infection | E-poster |
| 13:15 - 14:15 | 244 | Paediatric asthma and bronchopulmonary dysplasia | E-poster |
| 13:15 - 14:15 | 245 | In vitro modelling of lung disease: reach out to the next dimension | E-poster |
| 13:15 - 14:15 | 246 | Bronchiectasis | E-poster |
| 13:15 - 14:15 | 247 | Sleep across the lifespan in the new era of COVID - 19 | E-poster |
| 13:15 - 14:15 | 248 | Clinical effects of CFTR modulatory therapy and lung inflammation in children with cystic fibrosis | E-poster |
| 13:15 - 14:15 | 249 | New approaches to pulmonary rehabilitation and chronic care | E-poster |
| 13:15 - 14:15 | 250 | Pharmacology of airway diseases: clinical and laboratory studies | E-poster |
| 13:15 - 14:15 | 251 | Lung disease burden and management | E-poster |
| 13:15 - 14:15 | 252 | Early-life infections, wheezing and asthma | E-poster |
| 13:15 - 14:15 | 253 | Screening, diagnosis, management and prognosis of lung cancer | E-poster |
| 13:15 - 14:15 | 254 | Cystic fibrosis | E-poster |
| 13:15 - 14:15 | 255 | An update on respiratory physiotherapy and respiratory muscle function and training | E-poster |
| 13:15 - 14:15 | 256 | Comorbidities in airway obstructive diseases | E-poster |
| 13:15 - 14:15 | 257 | Prognostic markers of disease progression in non-idiopathic pulmonary fibrosis interstitial lung diseases | E-poster |
| 13:15 - 14:15 | 258 | Insights into rehabilitation and physiotherapy in COVID-19 | E-poster |
| 13:15 - 14:15 | 259 | Epidemiological aspects of tuberculosis | E-poster |
| 13:15 - 14:15 | 260 | Therapy of lung cancer | E-poster |
| 13:15 - 14:15 | 261 | Environmental and lifestyle impacts on chronic lung disease | E-poster |
| 13:15 - 14:15 | 262 | Exercise tolerance, supportive care and more in non-pulmonary fibrosis interstitial lung diseases | E-poster |
| 13:15 - 14:15 | 263 | Back to infection basics | E-poster |
| 13:15 - 14:15 | 264 | Clinical evolution, management and outcomes of patients with rare diffuse parenchymal lung diseases | E-poster |
| 13:15 - 14:15 | 265 | Pathogenic progress in airway diseases | E-poster |
| 13:15 - 14:15 | 266 | Inhaled treatments for COPD: real-world data | E-poster |
| 13:15 - 14:15 | 267 | Mechanical ventilation and weaning | E-poster |
| 13:15 - 14:15 | 268 | Health effects of tobacco and medical professionals | E-poster |
| 13:15 - 14:15 | 269 | Convex probe endobronchial ultrasound and radial probe endobronchial ultrasound | E-poster |
| 13:15 - 14:15 | 270 | Immunological and molecular characterisation of tuberculosis disease and infection | E-poster |
| 13:15 - 14:15 | 271 | From phenotyping to different diagnostic tools for sleep breathing disorders | E-poster |
| 13:15 - 14:15 | 272 | Future advances in respiratory physiology | E-poster |
| 13:15 - 14:15 | 273 | Asthma and COPD meets COVID-19: new diagnostic tools and results from clinical trials | E-poster |
| 13:15 - 14:15 | 274 | Interstitial lung disease, COVID-19 and friends | E-poster |
| 14:35 - 15:50 | 275 | CCC Interstitial lung diseases | Challenging clinical cases |
| 14:45 - 16:15 | 276 | New insights into the pathophysiology and prognosis of COPD | Oral Presentation |
| 14:45 - 16:15 | 277 | Advances in childhood asthma: biologics, biomarkers and infections | Oral Presentation |
| 14:45 - 16:15 | 278 | Tobacco and nicotine research during the pandemic | Oral Presentation |
| 14:45 - 16:15 | 279 | Insights into pulmonary embolism | Oral Presentation |
| 14:45 - 16:15 | 280 | Digital innovations in tuberculosis and implementation research in the era of COVID-19: collaborative activities between the WHO and ERS | Hot topics |
| 14:45 - 16:15 | 281 | Precision medicine in asthma and COPD | Symposium |
| 14:45 - 16:15 | 282 | The best of the European Respiratory Journal 2021 | Journal session |
| 14:45 - 16:15 | 283 | Respiratory critical care | State of the art session |
| 14:45 - 16:15 | 284 | LoF Lung cancer? | Lungs on fire |
| 14:45 - 16:15 | 285 | Innovation in thoracic surgery | Oral Presentation |
| 16:00 - 18:00 | 287 | Russian programme 2021 | Language session |
| 16:30 - 18:00 | 293 | Highlights in COVID-19 diagnosis and treatment | Oral Presentation |
| 16:30 - 18:00 | 294 | Monitoring of lung disease and CFTR function in children with cystic fibrosis | Oral Presentation |
| 16:30 - 18:00 | 295 | Impact of COVID - 19, quality assurance and technology on pulmonary function | Oral Presentation |
| 16:30 - 18:00 | 296 | Cellular and molecular involvement in lung injury and repair | Oral Presentation |
| 16:30 - 18:00 | 298 | New insights into nontuberculous mycobacteria disease: from diagnosis to treatment | Symposium |
| 16:30 - 18:00 | 299 | Pharmacology of lung immune responses: which pathways to target! | Symposium |
| 16:30 - 18:00 | 300 | The "State of the Art" in the diagnosis of bacterial, mycobacterial, and fungal pneumonias | Journal session |
| 16:30 - 18:00 | 301 | LoF Respiratory critical care / Sleep and Breathing disorders | Lungs on fire |
| 16:30 - 18:00 | 302 | Lung cancer grand round | Grand round |
| 16:30 - 18:00 | 303 | Innovation in respiratory training | Oral Presentation |